Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ergotamine, dihydroergotamine: current uses and problems.

P Tfelt-Hansen1

  • 1Department of Neurology, Glostrup Hospital, Glostrup, Denmark. tfelt@inet.uni2.dk

Current Medical Research and Opinion
|December 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interictal "patchy" regional cerebral blood flow patterns in migraine patients. A single photon emission computerized tomographic study.

European journal of neurology·2013
Same author

CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine.

Cephalalgia : an international journal of headache·2010
Same author

Posterior hypoperfusion in migraine without aura?

Cephalalgia : an international journal of headache·2010
Same author

Nitroglycerin provocation in normal subjects is not a useful human migraine model?

Cephalalgia : an international journal of headache·2009
Same author

Guidelines for controlled trials of drugs in tension-type headache: second edition.

Cephalalgia : an international journal of headache·2009
Same author

Prednisolone reduces nitric oxide-induced migraine.

European journal of neurology·2009
Same journal

Seasonal variations and prognosis of patients with sepsis, septic shock, and cardiogenic shock.

Current medical research and opinion·2026
Same journal

Therapeutic use of cardioselective beta-blockers for patients with chronic obstructive pulmonary disease: a review of current clinical evidence.

Current medical research and opinion·2026
Same journal

Treatment patterns among pediatric and adult patients with ulcerative colitis in the United States: a retrospective cohort study.

Current medical research and opinion·2026
Same journal

Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

Current medical research and opinion·2026
Same journal

RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

Current medical research and opinion·2026
Same journal

Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

Current medical research and opinion·2026
See all related articles

For acute migraine treatment, rectal ergotamine shows higher efficacy than rectal sumatriptan. Triptans are generally preferred over ergotamine due to fewer adverse events and greater effectiveness.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Ergotamine and triptans are common acute migraine treatments.
  • Comparative efficacy and route of administration are key considerations.

Purpose of the Study:

  • To compare the efficacy of ergotamine and sumatriptan for acute migraine treatment.
  • To evaluate different routes of administration for these medications.

Main Methods:

  • Review of randomized clinical trials comparing oral, rectal, and intranasal formulations.
  • Analysis of headache relief rates and adverse events.

Main Results:

  • Oral ergotamine was less effective than oral sumatriptan.
  • Rectal ergotamine demonstrated higher efficacy (73% headache relief) than rectal sumatriptan (63%).

Related Experiment Videos

  • Intranasal dihydroergotamine (DHE) was less effective than subcutaneous and intranasal sumatriptan.

    • Conclusions:

    • Triptans are generally preferred for acute migraine due to higher efficacy and fewer adverse events.
    • Rectal ergotamine is a viable option when oral triptans are ineffective.
    • Individualized dosing and avoiding daily use of ergotamine/DHE are crucial to prevent medication-overuse headache.